False

February 2016
Welcome to the February issue of The Medicine Maker! Gurus in this month’s cover feature explain the benefits and successes of transdermal drug delivery systems, while In My View covers subjects such as powder characterization in 3D printing; the dangers of poor translation in drug labels, and why needle-based is not disappearing anytime soon. In Departments, Stephen Colgan from Pfizer talks lean stability, and Shai Mulinari discusses the business of whistle blowers.
All Eyes on Patches
February 26, 2016
As medicine makers strive to overcome compliance and bioavailability challenges – and tackle controlled release in novel ways – transdermal drug delivery has presented itself as a rising star. Here, we speak with some of the companies and researchers riding the disruptive wave of innovation.
1 min read
Deep Breaths and Dry Powder
February 26, 2016
Drug delivery by inhalation promises convenience and speed in many applications from the emergency room to home-based self-administration. But to succeed, the interactions between formulation, device and metering mechanism must be perfectly balanced with human factors. These challenges are a source of fascination for those looking to deliver drugs less invasively.
1 min read
Deep Data Diver
February 26, 2016
Sitting Down With... Brian Overstreet, President at Advera Health Analytics, USA.
1 min read
Hail the Tattletale
February 26, 2016
In the US, whistle blowers who help uncover illegal offlabel promotion are usually awarded 15-25 percent of any recovered damages. Does incentivizing informants deter off-label drug marketing – and should other countries follow suit?
1 min read
Lean, Mean Stability Machine
February 24, 2016
Demonstrating the stability of drug formulations over a range of times and environmental conditions is an essential aspect of drug development. But what exactly should be monitored – and how often?
1 min read
Don't Neglect Needles!
February 24, 2016
New drug delivery technologies have their place, but so too do traditional needle injections – and we mustn’t forget that the latter can benefit from innovation too.
1 min read
Lost in Translation
February 24, 2016
Translating medicine packaging and labeling information accurately and appropriately for international markets is a challenge that cannot be faced lightly.
1 min read
A Future of Printing Powders?
February 24, 2016
For an industry progressing towards personalized medicines, 3D printing is starting to sound attractive. However, it is a technology that truly adheres to the ‘rubbish in, rubbish out’ adage – and that means we really need to understand our powders.
1 min read
Therapeutic Orphans
February 24, 2016
Neonates have, for too long, been underserved by drug development, potentially missing out on life-giving scientific advances. The International Neonatal Consortium is here to change that – for good.
1 min read
Problem Plants
February 24, 2016
Regulators come down hard on facilities that come up short.
1 min read
Distraction Tactics
February 24, 2016
Documents reveal that Turing and Valeant both used PR to divert attention from drug price hikes.
1 min read
Chemotherapy All Wrapped Up
February 24, 2016
Could exosome encapsulation be the secret to delivering higher potency in chemotherapy?
1 min read
Fighting Falsifiers
February 24, 2016
The EU takes the fight to the falsifiers with a new plan to implement packaging safety features.
1 min read
Competition Crackdown
February 24, 2016
GSK has been fined nearly $55 million by a UK watchdog over “pay-for-delay” deals.
1 min read
Suspended Amination
February 24, 2016
Chemists solve a 46-year- old problem to develop a new drug modification method.
1 min read
Why We Like Virus-Like Particles
February 24, 2016
Could Hepatitis E breathe new life into old drugs in the fight against cancer?
1 min read
Heroes of Medicine Making
February 24, 2016
How many people does it take to make a medicine?
1 min read
Browse by Topics
False
Recommended
False